Rapid clinical improvement of refractory subacute cutaneous lupus erythematosus with oral tyrosine kinase 2 inhibitor deucravacitinib: A case report.

Kurz, B; Ivanova, I; Drexler, K; Berneburg, M; Günther, F; Niebel, D.

Kurz B; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Ivanova I; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Drexler K; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Berneburg M; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Günther F; Department of Rheumatology, Asklepios Klinikum, Bad Abbach, Germany.
Niebel D; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.

J Eur Acad Dermatol Venereol ; 2023 Dec 07.

Article en En | MEDLINE | ID: mdl-38059369

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article